BIBCL
Invest Now
Start SIP in
BIBCL
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
Investment Returns
- Over 1 Month + 14.83%
- Over 3 Month -16.09%
- Over 6 Month -5.12%
- Over 1 Year -26.89%
Smart Investing Starts Here Start SIP with Bharat Immunological & Biologicals Corporation for Steady Growth!
Bharat Immunological & Biologicals Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Technicals
EMA & SMA
Current Price
₹23.00
-0.33
(-1.41%)
-
- Bearish Moving Average 0
-
- Bullish Moving Average 0
- 20 Day
- ₹22.97
- 50 Day
- ₹22.93
- 100 Day
- ₹23.72
- 200 Day
- ₹25.14
Resistance and Support
22.95
- R3 24.34
- R2 23.89
- R1 23.40
- S1 22.46
- S2 22.01
- S3 21.52
Bharat Immunological & Biologicals Corporation Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-08-16 | General Purpose. | |
2024-03-08 | Others | General Purpose |
2023-10-31 | Quarterly Results | |
2023-04-24 | Audited Results | |
2023-02-09 | Quarterly Results |
Bharat Immunological & Biologicals Corporation F&O
About Bharat Immunological & Biologicals Corporation
- NSE Symbol
- BIBCL
- BSE Symbol
- 524663
- ISIN
- INE994B01014
Similar Stocks to Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biologicals Corporation FAQs
Bharat Immunological & Biologicals Corporation share price is ₹23 As on 01 May, 2025 | 21:02
The Market Cap of Bharat Immunological & Biologicals Corporation is ₹99.3 Cr As on 01 May, 2025 | 21:02
The P/E ratio of Bharat Immunological & Biologicals Corporation is -5.4 As on 01 May, 2025 | 21:02
The PB ratio of Bharat Immunological & Biologicals Corporation is 1.1 As on 01 May, 2025 | 21:02
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.